New pulmonary arterial hypertension treatment offers hope for patients in advanced stage of disease

A relatively new therapy used to treat pulmonary arterial hypertension in those with mild to moderate disease was found to be effective at preventing death in those with more advanced disease. Results were published on Wednesday, May 28, in The New England Journal of Medicine and could have “transformative implications” for patients, according to an editorial that accompanied the study written by Bradley Maron, MD, Professor of Medicine and Director of the Hypertension Program at the University of Maryland School of Medicine.

Understanding how Creutzfeldt-Jakob disease hides in neurons for decades

In April 2025, three people in Oregon developed Creutzfeldt-Jakob disease (CJD), a rare, fatal neurological condition that is similar to bovine spongiform encephalopathy, also known as mad cow disease. It impacts one or two people per million each year, making the chances of three cases emerging in the same small geographic area quite low. This outbreak is currently under investigation, but there may not be a simple explanation; for the majority of CJD cases, the infectious source is unknown.

Anti-malarial medicines can help reduce body weight, researchers discover

In recent years, overweight and obesity have become a serious global health problem, posing significant risk factors for various diseases. Longing for a civilized and healthy lifestyle, more and more people are starting to pay attention to weight loss. Halofuginone (HF), a quinazoline ketone alkaloid found in the roots and leaves of Changshan, might be a new option for obesity treatment.